Helix BioMedix, Inc., a biopharmaceutical company specializing in peptides, recently announced the promotion of Robin L. Carmichael to the position of chief executive officer in addition to her current role as president. She will continue as a member of the company’s Board of Directors. Carmichael will be responsible for all aspects of management of Helix BioMedix including profits and losses, operations, sales, marketing, business development, pharmaceutical and consumer product programs, and research and development. She will report directly to the Board of Directors. Carmichael joined the company in 2007 as vice president of marketing and business development. She was promoted to chief operating officer in 2011, and later to president and chief operating officer in 2015.